Blog

New articles in the NEJM, Covid-19 & vaccine trials

While the world’s social media is inundated with populist commentary on the coronavirus, here is a tempered comment on what our appropriate response should be.

https://www.nejm.org/doi/full/10.1056/NEJMp2003762?query=TOC

#coronavirus

#vaccines”

Above article refers to Bill Gate’s position on Covid-19. In this he mentioned the importance of vaccines.

A vaccine to interrupt the transmission of tuberculosis is also needed, perhaps just as importantly as one for Covid-19 (Coronavirus). In contrast, currently there have been 3200 deaths in total attributed to Covid-19, whilst according to the World Health Organisation, 4400 lives are lost per day to TB.

In a recent publication from the International Society for Vaccines, their paper of the year in fact, highlights the advancements made in a recent TB vaccine study in which TASK was privileged to play a part:

https://www.isv-online.org/menu-database/paper-of-the-year

#coronavirus

#vaccines

#TB”

Further article on TB drug development:

Triumph-and-Tragedy-of-21st-Century-Tuberculosis-Drug-Development1